Actinium-targeted alpha radiotherapy is a promising approach for treating metastatic cancers, including prostate cancer. This approach requires doctors to obtain images of the radiotherapy agent as it moves to tumors, a process ...
Aug 28, 2023
0
1
In elderly patients with suspected prostate cancer, a prostate-specific membrane antigen positron emission tomography (PSMA PET) CT scan can diagnose advanced disease and aid in therapy selection without the need for a biopsy.
Aug 14, 2023
0
4
A new computational technique that combines genomic and tau PET imaging data promises a more personalized approach for subtyping Alzheimer's disease. Based on a novel clustering framework using sparse canonical correlation ...
Jun 27, 2023
0
5
By monitoring early-response biomarkers in men undergoing 177Lu-PSMA prostate cancer treatment, physicians can personalize dosing intervals, significantly improving patient outcomes.
Jun 27, 2023
0
17
Leaders from 12 nuclear medicine organizations around the world have issued a white paper about the challenges and opportunities in theranostics education. Published in the June issue of the Journal of Nuclear Medicine, the ...
Jun 23, 2023
0
3
A combination of pretherapy imaging and dosimetry can help ensure that patients with refractory differentiated thyroid cancer obtain the maximum benefit from radioactive iodine treatments following redifferentiation therapy. ...
Jun 22, 2023
0
4
A newly developed PET imaging agent, 64Cu-GPVI-Fc, can non-invasively identify pulmonary fibrosis in its early stages, reducing the need for unnecessary biopsies and allowing patients to begin treatment sooner. This research ...
Jun 21, 2023
0
5
A newly published meta-analysis indicates that amino acid PET can accurately differentiate recurrent or progressive brain metastases from treatment-related changes. A specificity of 84% suggests that it may reduce the number ...
May 12, 2023
0
2
A pair of articles published in the May issue of the Journal of Nuclear Medicine illustrate the promise of the novel FAPI radiotracer in diagnosing, staging, and treating multiple types of cancer. Results from the largest ...
May 2, 2023
0
10
A newly established PSMA PET scoring system can successfully predict whether metastatic castration-resistant prostate cancer (mCRPC) patients will respond to treatment with 177Lu-PSMA therapy. International, multicenter testing ...
Apr 19, 2023
0
6
